BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 11064104)

  • 1. Naked DNA when co-administered intranasally with heat-labile enterotoxin of Escherichia coli primes effectively for systemic B- and T-cell responses to the encoded antigen.
    Kanellos TS; Byarugaba DK; Russell PH; Howard CR; Partidos CD
    Immunol Lett; 2000 Nov; 74(3):215-20. PubMed ID: 11064104
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preferential induction of a Th1 immune response and inhibition of specific IgE antibody formation by plasmid DNA immunization.
    Raz E; Tighe H; Sato Y; Corr M; Dudler JA; Roman M; Swain SL; Spiegelberg HL; Carson DA
    Proc Natl Acad Sci U S A; 1996 May; 93(10):5141-5. PubMed ID: 8643542
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunization onto bare skin with heat-labile enterotoxin of Escherichia coli enhances immune responses to coadministered protein and peptide antigens and protects mice against lethal toxin challenge.
    Beignon AS; Briand JP; Muller S; Partidos CD
    Immunology; 2001 Mar; 102(3):344-51. PubMed ID: 11298834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasmid vectors encoding cholera toxin or the heat-labile enterotoxin from Escherichia coli are strong adjuvants for DNA vaccines.
    Arrington J; Braun RP; Dong L; Fuller DH; Macklin MD; Umlauf SW; Wagner SJ; Wu MS; Payne LG; Haynes JR
    J Virol; 2002 May; 76(9):4536-46. PubMed ID: 11932419
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative analysis of the mucosal adjuvanticity of the type II heat-labile enterotoxins LT-IIa and LT-IIb.
    Martin M; Metzger DJ; Michalek SM; Connell TD; Russell MW
    Infect Immun; 2000 Jan; 68(1):281-7. PubMed ID: 10603399
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of the antibody response to pneumococcal glycoconjugates and the effect of heat-labile enterotoxin on IGg subclasses after intranasal immunization.
    Jakobsen H; Adarna BC; Schulz D; Rappuoli R; Jonsdottir I
    J Infect Dis; 2001 May; 183(10):1494-500. PubMed ID: 11319685
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LT-IIc, a new member of the type II heat-labile enterotoxin family, exhibits potent immunomodulatory properties that are different from those induced by LT-IIa or LT-IIb.
    Nawar HF; Greene CJ; Lee CH; Mandell LM; Hajishengallis G; Connell TD
    Vaccine; 2011 Jan; 29(4):721-7. PubMed ID: 21095251
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rotavirus 2/6 virus-like particles administered intranasally in mice, with or without the mucosal adjuvants cholera toxin and Escherichia coli heat-labile toxin, induce a Th1/Th2-like immune response.
    Fromantin C; Jamot B; Cohen J; Piroth L; Pothier P; Kohli E
    J Virol; 2001 Nov; 75(22):11010-6. PubMed ID: 11602741
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of immune responses in parenteral FaeG DNA primed pigs boosted orally with F4 protein or reimmunized with the DNA vaccine.
    Melkebeek V; Verdonck F; Goddeeris BM; Cox E
    Vet Immunol Immunopathol; 2007 Apr; 116(3-4):199-214. PubMed ID: 17331591
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intranasal immunization with pneumococcal polysaccharide conjugate vaccines with nontoxic mutants of Escherichia coli heat-labile enterotoxins as adjuvants protects mice against invasive pneumococcal infections.
    Jakobsen H; Schulz D; Pizza M; Rappuoli R; Jónsdóttir I
    Infect Immun; 1999 Nov; 67(11):5892-7. PubMed ID: 10531245
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intranasal immunization of BALB/c mice with enterotoxigenic Escherichia coli colonization factor CS6 encapsulated in biodegradable poly(DL-lactide-co-glycolide) microspheres.
    Byrd W; Cassels FJ
    Vaccine; 2006 Feb; 24(9):1359-66. PubMed ID: 16233937
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chimeras of labile toxin one and cholera toxin retain mucosal adjuvanticity and direct Th cell subsets via their B subunit.
    Boyaka PN; Ohmura M; Fujihashi K; Koga T; Yamamoto M; Kweon MN; Takeda Y; Jackson RJ; Kiyono H; Yuki Y; McGhee JR
    J Immunol; 2003 Jan; 170(1):454-62. PubMed ID: 12496431
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The mucosal adjuvanticity of two nontoxic mutants of Escherichia coli heat-labile enterotoxin varies with immunization routes.
    Park EJ; Chang JH; Kim JS; Yum JS; Chung SI
    Exp Mol Med; 2000 Jun; 32(2):72-8. PubMed ID: 10926118
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intradermal administration of the Type II heat-labile enterotoxins LT-IIb and LT-IIc of enterotoxigenic Escherichia coli enhances humoral and CD8+ T cell immunity to a co-administered antigen.
    Hu JC; Mathias-Santos C; Greene CJ; King-Lyons ND; Rodrigues JF; Hajishengallis G; Ferreira LC; Connell TD
    PLoS One; 2014; 9(12):e113978. PubMed ID: 25536061
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Humoral and cellular immune responses in the murine respiratory tract following oral immunization with cholera toxin or Escherichia coli heat-labile enterotoxin.
    Ruedl C; Rieser C; Kofler N; Wick G; Wolf H
    Vaccine; 1996 Jun; 14(8):792-8. PubMed ID: 8817827
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The A subunit of Escherichia coli heat-labile enterotoxin functions as a mucosal adjuvant and promotes IgG2a, IgA, and Th17 responses to vaccine antigens.
    Norton EB; Lawson LB; Mahdi Z; Freytag LC; Clements JD
    Infect Immun; 2012 Jul; 80(7):2426-35. PubMed ID: 22526674
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heat-labile enterotoxin of Escherichia coli and its site-directed mutant LTK63 enhance the proliferative and cytotoxic T-cell responses to intranasally co-immunized synthetic peptides.
    Partidos CD; Salani BF; Pizza M; Rappuoli R
    Immunol Lett; 1999 Apr; 67(3):209-16. PubMed ID: 10369128
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcutaneous immunization: T cell responses and boosting of existing immunity.
    Hammond SA; Walwender D; Alving CR; Glenn GM
    Vaccine; 2001 Mar; 19(17-19):2701-7. PubMed ID: 11257412
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The adjuvant double mutant Escherichia coli heat labile toxin enhances IL-17A production in human T cells specific for bacterial vaccine antigens.
    Leach S; Clements JD; Kaim J; Lundgren A
    PLoS One; 2012; 7(12):e51718. PubMed ID: 23284753
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The immune response of two microbial antigens delivered intradermally, sublingually, or the combination thereof.
    Lee S; Picking WL; Tzipori S
    Microbes Infect; 2014 Sep; 16(9):796-803. PubMed ID: 25111827
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.